rs2275799

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_198060.4(NRAP):​c.844G>A​(p.Ala282Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.266 in 1,607,864 control chromosomes in the GnomAD database, including 58,513 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.29 ( 6650 hom., cov: 32)
Exomes 𝑓: 0.26 ( 51863 hom. )

Consequence

NRAP
NM_198060.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.923

Publications

27 publications found
Variant links:
Genes affected
NRAP (HGNC:7988): (nebulin related anchoring protein) Predicted to enable actin filament binding activity and muscle alpha-actinin binding activity. Predicted to be involved in cardiac muscle thin filament assembly. Predicted to be located in fascia adherens; muscle tendon junction; and myofibril. Predicted to be active in Z disc. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0042256117).
BP6
Variant 10-113650081-C-T is Benign according to our data. Variant chr10-113650081-C-T is described in ClinVar as [Benign]. Clinvar id is 1273205.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.357 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NRAPNM_198060.4 linkc.844G>A p.Ala282Thr missense_variant Exon 9 of 42 ENST00000359988.4 NP_932326.2 Q86VF7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NRAPENST00000359988.4 linkc.844G>A p.Ala282Thr missense_variant Exon 9 of 42 1 NM_198060.4 ENSP00000353078.3 Q86VF7-1
NRAPENST00000369358.8 linkc.844G>A p.Ala282Thr missense_variant Exon 9 of 42 1 ENSP00000358365.4 A0A0A0MRM2
NRAPENST00000360478.7 linkc.844G>A p.Ala282Thr missense_variant Exon 9 of 41 1 ENSP00000353666.3 Q86VF7-4
NRAPENST00000369360.7 linkc.844G>A p.Ala282Thr missense_variant Exon 9 of 41 5 ENSP00000358367.3 Q86VF7-3

Frequencies

GnomAD3 genomes
AF:
0.292
AC:
44423
AN:
151954
Hom.:
6648
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.363
Gnomad AMI
AF:
0.271
Gnomad AMR
AF:
0.245
Gnomad ASJ
AF:
0.360
Gnomad EAS
AF:
0.205
Gnomad SAS
AF:
0.240
Gnomad FIN
AF:
0.291
Gnomad MID
AF:
0.383
Gnomad NFE
AF:
0.267
Gnomad OTH
AF:
0.290
GnomAD2 exomes
AF:
0.264
AC:
66184
AN:
251110
AF XY:
0.265
show subpopulations
Gnomad AFR exome
AF:
0.364
Gnomad AMR exome
AF:
0.177
Gnomad ASJ exome
AF:
0.369
Gnomad EAS exome
AF:
0.210
Gnomad FIN exome
AF:
0.296
Gnomad NFE exome
AF:
0.271
Gnomad OTH exome
AF:
0.286
GnomAD4 exome
AF:
0.264
AC:
384051
AN:
1455792
Hom.:
51863
Cov.:
30
AF XY:
0.264
AC XY:
191291
AN XY:
724602
show subpopulations
African (AFR)
AF:
0.370
AC:
12329
AN:
33304
American (AMR)
AF:
0.182
AC:
8143
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.362
AC:
9441
AN:
26066
East Asian (EAS)
AF:
0.195
AC:
7739
AN:
39688
South Asian (SAS)
AF:
0.251
AC:
21617
AN:
86118
European-Finnish (FIN)
AF:
0.300
AC:
15989
AN:
53316
Middle Eastern (MID)
AF:
0.311
AC:
1793
AN:
5760
European-Non Finnish (NFE)
AF:
0.262
AC:
290488
AN:
1106670
Other (OTH)
AF:
0.274
AC:
16512
AN:
60174
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.451
Heterozygous variant carriers
0
13393
26787
40180
53574
66967
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9732
19464
29196
38928
48660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.292
AC:
44444
AN:
152072
Hom.:
6650
Cov.:
32
AF XY:
0.289
AC XY:
21495
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.362
AC:
15017
AN:
41490
American (AMR)
AF:
0.245
AC:
3743
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.360
AC:
1249
AN:
3466
East Asian (EAS)
AF:
0.205
AC:
1058
AN:
5156
South Asian (SAS)
AF:
0.239
AC:
1151
AN:
4812
European-Finnish (FIN)
AF:
0.291
AC:
3071
AN:
10562
Middle Eastern (MID)
AF:
0.388
AC:
114
AN:
294
European-Non Finnish (NFE)
AF:
0.267
AC:
18175
AN:
67988
Other (OTH)
AF:
0.294
AC:
620
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1594
3188
4781
6375
7969
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
434
868
1302
1736
2170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.274
Hom.:
25296
Bravo
AF:
0.292
TwinsUK
AF:
0.270
AC:
1001
ALSPAC
AF:
0.262
AC:
1010
ESP6500AA
AF:
0.362
AC:
1595
ESP6500EA
AF:
0.278
AC:
2389
ExAC
AF:
0.267
AC:
32457
Asia WGS
AF:
0.253
AC:
882
AN:
3478
EpiCase
AF:
0.274
EpiControl
AF:
0.279

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27443559) -

not specified Benign:1
Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

NRAP-related disorder Benign:1
Oct 22, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
17
DANN
Benign
0.94
DEOGEN2
Benign
0.022
.;.;T;T
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.091
FATHMM_MKL
Benign
0.17
N
LIST_S2
Benign
0.51
T;T;T;T
MetaRNN
Benign
0.0042
T;T;T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
1.9
L;L;.;L
PhyloP100
0.92
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-1.9
N;N;N;N
REVEL
Benign
0.12
Sift
Benign
0.32
T;T;T;T
Sift4G
Benign
0.40
T;T;T;T
Polyphen
0.036, 0.038
.;B;.;B
Vest4
0.018
MPC
0.079
ClinPred
0.019
T
GERP RS
5.2
Varity_R
0.067
gMVP
0.23
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2275799; hg19: chr10-115409840; COSMIC: COSV63492370; API